Mineralys Therapeutics Funding: $328M Raised, Series A
Mineralys Therapeutics is based in Philadelphia, PA. It has raised $328M in total funding. Latest round: Series A.
Mineralys Therapeutics funding overview
Mineralys Therapeutics is based in Philadelphia, PA. Mineralys Therapeutics has raised $328M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Mineralys Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include HBM Healthcare Investments, Samsara BioCapital, Catalys Pacific, Adam Street Partners. 4 distinct backers are named across the disclosed rounds.
Mineralys Therapeutics at a glance
Total raised
$328M
Latest round
Series A
Latest round date
April 2021
Headquarters
Philadelphia, PA
Notable investors
HBM Healthcare Investments, Samsara BioCapital, Catalys Pacific, Adam Street Partners
Frequently asked about Mineralys Therapeutics funding
How much has Mineralys Therapeutics raised?
Mineralys Therapeutics has raised $328M in total disclosed funding across the rounds on record.
Who has invested in Mineralys Therapeutics?
HBM Healthcare Investments, Samsara BioCapital, Catalys Pacific, Adam Street Partners are named among the investors backing Mineralys Therapeutics.
What was the latest Mineralys Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2021.
Where is Mineralys Therapeutics based?
Mineralys Therapeutics is based in Philadelphia, PA.
When did Mineralys Therapeutics last raise?
The last disclosed Mineralys Therapeutics round closed in April 2021 at Series A.
Every Mineralys Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Philadelphia at a similar stage.
